FOXP3 protects conventional human T cells from premature restimulation-induced cell death.


Journal

Cellular & molecular immunology
ISSN: 2042-0226
Titre abrégé: Cell Mol Immunol
Pays: China
ID NLM: 101242872

Informations de publication

Date de publication:
01 2021
Historique:
received: 20 05 2019
accepted: 02 10 2019
pubmed: 30 10 2019
medline: 28 12 2021
entrez: 30 10 2019
Statut: ppublish

Résumé

The adaptive immune response relies on specific apoptotic programs to maintain homeostasis. Conventional effector T cell (Tcon) expansion is constrained by both forkhead box P3 (FOXP3)

Identifiants

pubmed: 31659245
doi: 10.1038/s41423-019-0316-z
pii: 10.1038/s41423-019-0316-z
pmc: PMC7852538
doi:

Substances chimiques

CD48 Antigen 0
CD48 protein, human 0
FOXP3 protein, human 0
Forkhead Transcription Factors 0
Receptors, Antigen, T-Cell 0
SH2D1A protein, human 0
Signaling Lymphocytic Activation Molecule Associated Protein 0
TP53 protein, human 0
Tumor Suppressor Protein p53 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

194-205

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM105821
Pays : United States

Références

Strasser, A. & Pellegrini, M. T-lymphocyte death during shutdown of an immune response. Trends Immunol. 25, 610–615 (2004).
pubmed: 15489190
Snow, A. L., Pandiyan, P., Zheng, L., Krummey, S. M. & Lenardo, M. J. The power and the promise of restimulation-induced cell death in human immune diseases. Immunol. Rev. 236, 68–82 (2010).
pubmed: 20636809 pmcid: 2907538
Snow, A. L. et al. Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency. J. Clin. Invest. 119, 2976–2989 (2009).
pubmed: 19759517 pmcid: 2752081
Bassiri, H., Janice Yeo, W. C., Rothman, J., Koretzky, G. A. & Nichols, K. E. X-linked lymphoproliferative disease (XLP): a model of impaired anti-viral, anti-tumor and humoral immune responses. Immunol. Res. 42, 145–159 (2008).
pubmed: 18815745
Hislop, A. D. et al. Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets. Blood 116, 3249–3257 (2010).
pubmed: 20644117
Wherry, E. J. et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4, 225–234 (2003).
pubmed: 12563257
Combadiere, B. et al. Qualitative and quantitative contributions of the T cell receptor zeta chain to mature T cell apoptosis. J. Exp. Med. 183, 2109–2117 (1996).
pubmed: 8642321
She, J., Matsui, K., Terhorst, C. & Ju, S. T. Activation-induced apoptosis of mature T cells is dependent upon the level of surface TCR but not on the presence of the CD3 zeta ITAM. Int. Immunol. 10, 1733–1740 (1998).
pubmed: 9846702
Lenardo, M. J. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353, 858–861 (1991).
pubmed: 1944559
Boehme, S. A. & Lenardo, M. J. Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle. Eur. J. Immunol. 23, 1552–1560 (1993).
pubmed: 8325332
Schmitz, I. et al. An IL-2-dependent switch between CD95 signaling pathways sensitizes primary human T cells toward CD95-mediated activation-induced cell death. J. Immunol. 171, 2930–2936 (2003).
pubmed: 12960316
Muppidi, J. R. & Siegel, R. M. Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death. Nat. Immunol. 5, 182–189 (2004).
pubmed: 14745445
Chen, G. et al. Increased proliferation of CD8+ T cells in SAP-deficient mice is associated with impaired activation-induced cell death. Eur. J. Immunol. 37, 663–674 (2007).
pubmed: 17266174
Katz, G., Krummey, S. M., Larsen, S. E., Stinson, J. R. & Snow, A. L. SAP facilitates recruitment and activation of LCK at NTB-A receptors during restimulation-induced cell death. J. Immunol. 192, 4202–4209 (2014).
pubmed: 24688028
Ruffo, E. et al. Inhibition of diacylglycerol kinase alpha restores restimulation-induced cell death and reduces immunopathology in XLP-1. Sci. Transl. Med. 8, 321ra7 (2016).
pubmed: 26764158 pmcid: 4918505
Shinozaki, K. et al. Activation-dependent T cell expression of the X-linked lymphoproliferative disease gene product SLAM-associated protein and its assessment for patient detection. Int Immunol. 14, 1215–1223 (2002).
pubmed: 12356686
Mehrle, S., Frank, S., Schmidt, J., Schmidt-Wolf, I. G. & Marten, A. SAP and SLAM expression in anti-CD3 activated lymphocytes correlates with cytotoxic activity. Immunol. Cell Biol. 83, 33–39 (2005).
pubmed: 15661039
Katz, G. et al. FOXP3 renders activated human regulatory T cells resistant to restimulation-induced cell death by suppressing SAP expression. Cell Immunol. 327, 54–61 (2018).
Fritzsching, B. et al. In contrast to effector T cells, CD4+CD25+FoxP3+ regulatory T cells are highly susceptible to CD95 ligand-but not to TCR-mediated cell death. J. Immunol. 175, 32–36 (2005).
pubmed: 15972628
Bhaskaran, N. et al. Transforming growth factor-beta1 sustains the survival of Foxp3(+) regulatory cells during late phase of oropharyngeal candidiasis infection. Mucosal Immunol. 9, 1015–1026 (2016).
pubmed: 26530137
Weiss, E. M. et al. Foxp3-mediated suppression of CD95L expression confers resistance to activation-induced cell death in regulatory T cells. J. Immunol. 187, 1684–1691 (2011).
pubmed: 21746966
Gavin, M. A. et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc. Natl Acad. Sci. USA 103, 6659–6664 (2006).
pubmed: 16617117
Miyao, T. et al. Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity 36, 262–275 (2012).
pubmed: 22326580
Wang, J., Ioan-Facsinay, A., van der Voort, E. I., Huizinga, T. W. & Toes, R. E. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur. J. Immunol. 37, 129–138 (2007).
pubmed: 17154262
McMurchy, A. N. et al. A novel function for FOXP3 in humans: intrinsic regulation of conventional T cells. Blood 121, 1265–1275 (2013).
pubmed: 23169781
Torgerson, T. R. et al. FOXP3 inhibits activation-induced NFAT2 expression in T cells thereby limiting effector cytokine expression. J. Immunol. 183, 907–915 (2009).
pubmed: 19564342 pmcid: 2778477
Allan, S. E. et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int. Immunol. 19, 345–354 (2007).
pubmed: 17329235
Cavatorta, D. J., Erb, H. N. & Felippe, M. J. Activation-induced FoxP3 expression regulates cytokine production in conventional T cells stimulated with autologous dendritic cells. Clin. Vaccin. Immunol. 19, 1583–1592 (2012).
Ziegler, S. F. FOXP3: not just for regulatory T cells anymore. Eur. J. Immunol. 37, 21–23 (2007).
pubmed: 17183612
Katz, G. & Snow, A. L. Fluorescence-activated cell sorting-based quantitation of T cell receptor restimulation-induced cell death in activated, primary human T cells. Methods Mol. Biol. 979, 15–23 (2013).
pubmed: 23397384
Magg, T., Mannert, J., Ellwart, J. W., Schmid, I. & Albert, M. H. Subcellular localization of FOXP3 in human regulatory and nonregulatory T cells. Eur. J. Immunol. 42, 1627–1638 (2012).
pubmed: 22678915
Cencioni, M. T. et al. FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients. Cell Death Dis. 6, e1785 (2015).
pubmed: 26068793 pmcid: 4669842
Varadhachary, A. S., Perdow, S. N., Hu, C., Ramanarayanan, M. & Salgame, P. Differential ability of T cell subsets to undergo activation-induced cell death. Proc. Natl Acad. Sci. USA 94, 5778–5783 (1997).
pubmed: 9159150
Cruz, A. C. et al. Fas/CD95 prevents autoimmunity independently of lipid raft localization and efficient apoptosis induction. Nat. Commun. 7, 13895 (2016).
pubmed: 28008916 pmcid: 5196435
Snow, A. L. et al. Critical role for BIM in T cell receptor restimulation-induced death. Biol. Direct 3, 34 (2008).
pubmed: 18715501 pmcid: 2529272
Dhein, J., Walczak, H., Baumler, C., Debatin, K. M. & Krammer, P. H. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373, 438–441 (1995).
pubmed: 7530335
Wu, N. & Veillette, A. SLAM family receptors in normal immunity and immune pathologies. Curr. Opin. Immunol. 38, 45–51 (2016).
pubmed: 26682762
Kwon, H. K., Chen, H. M., Mathis, D. & Benoist, C. Different molecular complexes that mediate transcriptional induction and repression by FoxP3. Nat. Immunol. 18, 1238–1248 (2017).
pubmed: 28892470 pmcid: 5679728
Sadlon, T. J. et al. Genome-wide identification of human FOXP3 target genes in natural regulatory T cells. J. Immunol. 185, 1071–1081 (2010).
pubmed: 20554955
McArdel, S. L., Brown, D. R., Sobel, R. A. & Sharpe, A. H. Anti-CD48 monoclonal antibody attenuates experimental autoimmune encephalomyelitis by limiting the number of pathogenic CD4+ T cells. J. Immunol. 197, 3038–3048 (2016).
pubmed: 27581174 pmcid: 5356934
Elishmereni, M. & Levi-Schaffer, F. CD48: a co-stimulatory receptor of immunity. Int. J. Biochem Cell Biol. 43, 25–28 (2011).
pubmed: 20833258
Pahima, H., Puzzovio, P. G. & Levi-Schaffer, F. 2B4 and CD48: a powerful couple of the immune system. Clin. Immunol. 204, 64–68 (2019).
Ramaswamy, M. et al. Specific elimination of effector memory CD4+ T cells due to enhanced Fas signaling complex formation and association with lipid raft microdomains. Cell Death Differ. 18, 712–720 (2011).
pubmed: 21164519
Fischer, M. Census and evaluation of p53 target genes. Oncogene 36, 3943–3956 (2017).
pubmed: 28288132 pmcid: 5511239
White, E. Autophagy andp53. Cold Spring Harb. Perspect. Med. 6, a026120 (2016).
pubmed: 27037419 pmcid: 4817743
Wei, J. et al. Autophagy enforces functional integrity of regulatory T cells by coupling environmental cues and metabolic homeostasis. Nat. Immunol. 17, 277–285 (2016).
pubmed: 26808230 pmcid: 4755832
Corrado, M. et al. Macroautophagy inhibition maintains fragmented mitochondria to foster T cell receptor-dependent apoptosis. EMBO J. 35, 1793–1809 (2016).
pubmed: 27390127 pmcid: 5010050
Guo, S. et al. A rapid and high content assay that measures cyto-ID-stained autophagic compartments and estimates autophagy flux with potential clinical applications. Autophagy 11, 560–572 (2015).
pubmed: 25714620 pmcid: 4502761
Ichimura, Y. et al. A ubiquitin-like system mediates protein lipidation. Nature 408, 488–492 (2000).
pubmed: 11100732
Maira, S. M. et al. Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity. Mol. Cancer Ther. 7, 1851–1863 (2008).
pubmed: 18606717
Cencioni, M. T. et al. FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients. Cell Death Dis. 6, e1741 (2015).
pubmed: 25950471 pmcid: 4669684
Shi, G. et al. Unlike Th1, Th17 cells mediate sustained autoimmune inflammation and are highly resistant to restimulation-induced cell death. J. Immunol. 183, 7547–7556 (2009).
pubmed: 19890052 pmcid: 2958176
Weant, A. E. et al. Apoptosis regulators Bim and Fas function concurrently to control autoimmunity and CD8+ T cell contraction. Immunity 28, 218–230 (2008).
pubmed: 18275832
Muhammad, A. et al. Sequential cooperation of CD2 and CD48 in the buildup of the early TCR signalosome. J. Immunol. 182, 7672–7680 (2009).
pubmed: 19494291
Gonzalez-Cabrero, J. et al. CD48-deficient mice have a pronounced defect in CD4(+) T cell activation. Proc. Natl Acad. Sci. USA 96, 1019–1023 (1999).
pubmed: 9927686
Dowling, S. D. & Macian, F. Autophagy and T cell metabolism. Cancer Lett. 419, 20–26 (2018).
pubmed: 29339212 pmcid: 5937942
Radoshevich, L. et al. ATG12 conjugation to ATG3 regulates mitochondrial homeostasis and cell death. Cell 142, 590–600 (2010).
pubmed: 20723759 pmcid: 2925044
Pua, H. H., Guo, J., Komatsu, M. & He, Y. W. Autophagy is essential for mitochondrial clearance in mature T lymphocytes. J. Immunol. 182, 4046–4055 (2009).
pubmed: 19299702
McArdel, S. L., Terhorst, C. & Sharpe, A. H. Roles of CD48 in regulating immunity and tolerance. Clin. Immunol. 164, 10–20 (2016).
pubmed: 26794910 pmcid: 4860950
Abadia-Molina, A. C. et al. CD48 controls T-cell and antigen-presenting cell functions in experimental colitis. Gastroenterology 130, 424–434 (2006).
pubmed: 16472597

Auteurs

Kelsey Voss (K)

Department of Pharmacology & Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, 20817, USA.

Camille Lake (C)

Department of Pharmacology & Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, 20817, USA.

Christopher R Luthers (CR)

Department of Pharmacology & Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, 20817, USA.

Nathaniel M Lott (NM)

The American Genome Center (TAGC), Collaborative Health Initiative Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.

Batsukh Dorjbal (B)

Department of Pharmacology & Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, 20817, USA.

Swadhinya Arjunaraja (S)

Department of Pharmacology & Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, 20817, USA.

Bradly M Bauman (BM)

Department of Pharmacology & Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, 20817, USA.

Anthony R Soltis (AR)

The American Genome Center (TAGC), Collaborative Health Initiative Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.

Gauthaman Sukumar (G)

The American Genome Center (TAGC), Collaborative Health Initiative Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.

Clifton L Dalgard (CL)

The American Genome Center (TAGC), Collaborative Health Initiative Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Department of Anatomy, Physiology & Genetics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.

Andrew L Snow (AL)

Department of Pharmacology & Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, 20817, USA. andrew.snow@usuhs.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH